Novartis AG
CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES AND USES THEREFORE

Last updated:

Abstract:

The invention provides compositions and methods for treating diseases associated with expression of a tumor antigen as described herein by administration of a cell comprising a chimeric antigen receptor that binds a B-Cell antigen and a chimeric antigen receptor which binds a tumor antigen.

Status:
Application
Type:

Utility

Filling date:

3 Mar 2017

Issue date:

10 Sep 2020